| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |